查詢結果分析
相關文獻
- Short-and Long-Term Effects of Hormone Replacement Therapy on Cardiovascular Risk Factors in Postmenopausal Women
- 停經婦女補充女性荷爾蒙之利弊
- 中年婦女血中荷爾蒙濃度與停經狀態--橫斷式研究初探
- Effects of Sequential and Cyclic Combined Postmenopausal Hormone Replacement Therapy on Uterine Bleeding and Climacteric Symptoms
- 婦女接受荷爾蒙補充療法的遵從行為與其更年期症狀緩解之相關研究
- 荷爾蒙補充療法之安全性
- 臺北縣金山鄉衛生所就診婦女使用荷爾蒙補充療法分析
- 停經婦女荷爾蒙補充療法的利弊考量
- 荷爾蒙補充療法之利與弊
- 荷爾蒙補充療法的相關健康議題
頁籤選單縮合
題 名 | Short-and Long-Term Effects of Hormone Replacement Therapy on Cardiovascular Risk Factors in Postmenopausal Women=荷爾蒙補充療法對停經後婦女心血管危險因子之短期與長期效應 |
---|---|
作 者 | 陳芳萍; 李寧; 宋永魁; 黃國恩; | 書刊名 | 長庚醫學 |
卷 期 | 24:7 2001.07[民90.07] |
頁 次 | 頁431-439 |
分類號 | 418.27 |
關鍵詞 | 荷爾蒙補充療法; 脂肪蛋白代謝; 血中恆定因子; 血子板凝集; Hormone replacement therapy; Lipoprotein profile; Hemostatic parameters; Platelet aggregation; |
語 文 | 英文(English) |
英文摘要 | BACKGROUND: The beneficial effect of hormone replacement therapy (HRT) on cardiovascular disease has been documented in postmenopausal women, but has a significant time trend. Thus, it is worthwhile to further study whether there are different effects on cardiovascular factors between short-and long-term use of HRT. METHODS: Prospective study of the changes on lipoprotein profile, hemostatic factors, and platelet aggregation was evaluated in 21 postmenopausal women receiving oral E2 valerate (2 mg/d) combined with medroxyprogesterone acetate (10 mg/d) during the last 10 days of each 21-day cycle. The treatment period was 24 months. RESULTS: During the 24 months of treatment, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and atherogenic indices- total cholesterol-to-high-density lipoprotein cholesterol (HDL-C) and LDL-C-to-HDL-C, were significantly reduced. The concentrations of tissue plasminogen activator and plasminogen activator inhibitor-1 were significantly reduced after 12 months of HRT. In addition, the concentrations of antithrombin III were significantly increased, but protein S was statistically decreased during the 18 months of HRT. The maximum aggregation and slope of platelet aggregation were significantly reduced only during the first 12 months of HRT. CONCLUSIONS: This study demonstrates that there were some differences in cardiovascular risk factors between short- and long-term HRT, especially in changes in platelet aggregation and hemostatic factors. However, the long-term favorable effect on lipoprotein metabolism and fibrinolytic activity among hormone users may explain, in part, the inverse association between HRT and cardiovascular disease. |
本系統中英文摘要資訊取自各篇刊載內容。